Demo Data from SIGIR 2026 / reviewers in the wild / expert
Verónica Torrano
dblp:254/3285
· DBLP profile ↗
1ranked-venue papers
0as first author
0since 2021 · last 2019
0000-0002-4252-1977ORCID · reported
Domains — the database's venue-derived domains; a paper can count in several
Applied, interdisciplinary, general and emerging computing · 1
Expertise — from the expertise taxonomy: the topics of the expert's papers under the CCF categories. A weight counts papers with recency: 1 for a paper about the topic, 0.3 when the topic is its context, halved every five years.
| Interdisciplinary, comprehensive, and emerging computing
1 paper |
Bioinformatics and computational biology · 100% |
Topics — the 2 heaviest of 2, each with the papers that count most for it
| Topic | Weight | Papers | Last | Evidence papers |
|---|---|---|---|---|
Bioinformatics and computational biology › drug discovery › target identification
drug target prediction |
0.4 | 1 | 2019 | rMTA: robust metabolic transformation analysis · Bioinform. 2019 |
Bioinformatics and computational biology › systems biology
metabolic network analysis |
0.4 | 1 | 2019 | rMTA: robust metabolic transformation analysis · Bioinform. 2019 |
Methods — techniques the papers use, named apart from their topics
worst-case scenario analysis · 0.4minimization of metabolic adjustment · 0.4
| Year | Publication | Venue | Position |
|---|---|---|---|
| 2019 | rMTA: robust metabolic transformation analysisabstractMOTIVATION: The development of computational tools exploiting -omics data and high-quality genome-scale metabolic networks for the identification of novel drug targets is a relevant topic in Systems Medicine. Metabolic Transformation Algorithm (MTA) is one of these tools, which aims to identify targets that transform a disease metabolic state back into a healthy state, with potential application in any disease where a clear metabolic alteration is observed. RESULTS: Here, we present a robust extension to MTA (rMTA), which additionally incorporates a worst-case scenario analysis and minimization of metabolic adjustment to evaluate the beneficial effect of gene knockouts. We show that rMTA complements MTA in the different datasets analyzed (gene knockout perturbations in different organisms, Alzheimer's disease and prostate cancer), bringing a more accurate tool for predicting therapeutic targets. AVAILABILITY AND IMPLEMENTATION: rMTA is freely available on The Cobra Toolbox: https://opencobra.github.io/cobratoolbox/latest/. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online. Luis Vitores Valcarcel, Verónica Torrano, Luis Tobalina, Arkaitz Carracedo, Francisco J. Planes |
Bioinform. | 2 |